Skip to content
Research Article Open access CC BY 4.0

An In-silico Study Showing Potentials of Selected Anthocyanin Derivatives against Uropathogenic E. coli Adhesin Protein

Abhishek Chowdhury, Manabendra Dutta Choudhury, Monjur Ahmed Laskar

South Asian Journal of Research in Microbiology · pp. 15–26 · Published 17 Jun 2022

10.9734/sajrm/2022/v12i430282

Abstract

Urinary tract infections (UTI) caused primarily by uropathogenic Escherichia coli (UPEC) are indeed an extremely contagious disease that affects people all over the world. FimH is a major virulence component in UTI pathogenesis, and inhibiting FimH function can be an efficient means to disarm UPEC bacteria, as well as a crucial target in the development of non-antibiotic mediated UTI treatment options. The goal of this study was to identify anthocyanins in plant parts and assess their pharmacological characteristics. A computational methodology was used to predict the pharmacological characteristics of such substances. Compounds with pharmacophores comparable to those of known fimH inhibitors were chosen. Following that, additional research was carried out to assess their drug similarity, inhibitory potential, and IC50 values. Thus, the present study reports few novel fimH inhibitors derived from the selected plant’s phytochemicals, and is significant owing to their therapeutic implication as a non-antibiotic mediated therapy for UTI.

Urinary tract infections Escherichia coli fimH computer aided drug design

References (18)

  1. 1 Anti-virulence strategies to combat bacteria-mediated disease [DOI]
  2. 2 Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections [DOI]
  3. 3 UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial Strategies [DOI]
  4. 4 In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. [DOI]
  5. 5 Diagnosis and treatment of urinary tract infections across age groups [DOI]
  6. 6 Treatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors [DOI]
  7. 7 Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA) [DOI]
  8. 8 FimH Antagonists for the Oral Treatment of Urinary Tract Infections: From Design and Synthesis to in Vitro and in Vivo Evaluation [DOI]
  9. 9 Fresh Approaches to Anti-Infective Therapies [DOI]
  10. 10 Chemical Strategies To Target Bacterial Virulence [DOI]
  11. 11 Who will develop new antibacterial agents? [DOI]
  12. 12 Anti-adhesion methods as novel therapeutics for bacterial infections [DOI]
  13. 13 Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn’s disease [DOI]
  14. 14 Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU) [DOI]
  15. 15 The expanding role of fluoroquinolones [DOI]
  16. 16 Trimethoprim-Sulfamethoxazole May No Longer Be Acceptable for the Treatment of Acute Uncomplicated Cystitis in the United States [DOI]
  17. 17 Binding-competent states for L-arginine in E. coli arginine repressor apoprotein [DOI]
  18. 18 Infectious Disease Clinics of North America [DOI]

Cited by 2

Bio-Computational Prediction of Novel Epitopes on VP2 Protein of Infectious Bursal Disease Virus

Niraj K Singh, Anuj Tyagi, Sumit Singhal, Anjay, Yogendra Singh Jadoun, Anuradha Kumari · Journal of Advances in Microbiology · 2024

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

60

Page views

0

PDF downloads

38

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.